PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2008.40.3.1012008403101Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast CancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Sung-Hyun Kim, Dae-Cheol Kim, Jin-Hwa Lee, Hyung-Sik Lee, Se-Heun Cho, Hyo-Jin Kimhttp://www.e-crt.org/upload/pdf/crt-40-101.pdf, http://www.e-crt.org/upload/pdf/crt-40-101.pdf
Breast Diseases: A Year Book Quarterly10.1016/j.breastdis.2011.10.0142011224413-415Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancerR. Rozner, A.D. Seidmanhttps://api.elsevier.com/content/article/PII:S1043321X1100289X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X1100289X?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-012-1824-z20126951345-1352A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancerN. Karachaliou, Ch. Kouroussis, P. Papakotoulas, K. Kalbakis, K. Tryfonidis, N. Vardakis, E. Poppis, V. Georgoulias, D. Mavroudishttp://link.springer.com/content/pdf/10.1007/s00280-012-1824-z.pdf, http://link.springer.com/article/10.1007/s00280-012-1824-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-012-1824-z
European Journal of Cancer Supplements10.1016/s1359-6349(05)80760-8200532129-130463 PUBLICATION Gemcitabine (GEM) plus oxaliplatin (LOHP) as salvage treatment in anthracycline and taxane pretreated patients with advanced breast cancer (ABC)https://api.elsevier.com/content/article/PII:S1359634905807608?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905807608?httpAccept=text/plain
Journal of Breast Cancer10.4048/jbc.2014.17.4.3392014174339Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer PatientsJung Sun Kim, In Hae Park, Keun Seok Lee, Jungsil Rohttps://synapse.koreamed.org/DOIx.php?id=10.4048/jbc.2014.17.4.339, https://synapse.koreamed.org/pdf/10.4048/jbc.2014.17.4.339, https://ejbc.kr/DOIx.php?id=10.4048/jbc.2014.17.4.339
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(07)80372-92007183313Phase II and Pharmacological Study of Oral Paclitaxel (Paxoral) Plus Ciclosporin in Anthracycline-Pretreated Metastatic Breast CancerR.M. Elledgehttps://api.elsevier.com/content/article/PII:S1043321X07803729?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X07803729?httpAccept=text/plain
European Journal of Cancer Supplements10.1016/s1359-6349(05)80751-7200532127454 PUBLICATION phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)https://api.elsevier.com/content/article/PII:S1359634905807517?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905807517?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2008.n.026200883234-241Phase I/II Study of Ixabepilone plus Capecitabine in Anthracycline–Pretreated/Resistant and Taxane-Resistant Metastatic Breast CancerCraig Bunnell, Linda Vahdat, Lee Schwartzberg, Julie Gralow, Judith Klimovsky, Valerie Poulart, Ronald Peck, Eva Thomashttps://api.elsevier.com/content/article/PII:S1526820911705134?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911705134?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-011-1728-32011692515-522An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II studyZhonghua Wang, Jingsong Lu, Shiangjiin Leaw, Xiaonan Hong, Jialei Wang, Zhimin Shao, Xichun Huhttp://link.springer.com/content/pdf/10.1007/s00280-011-1728-3.pdf, http://link.springer.com/article/10.1007/s00280-011-1728-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-011-1728-3
Cancer Treatment Reviews10.1016/s0305-7372(05)80004-0200531S17-S22Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?C LEVY, P FUMOLEAUhttps://api.elsevier.com/content/article/PII:S0305737205800040?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737205800040?httpAccept=text/plain